As a new-type foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply original factory goods of multiple well-known brands for 5-hydroxytryptophan. With R&D capabilities, HiSiaddi has conducted multiple rounds of inspections of 5-HTP manufacturers through technological transformation cooperation, gaining objective and in-depth understanding of various brands. Therefore, we frequently analyze different 5-HTP manufacturers for clients to help them select suitable products. Below is a brand recommendation case. Please contact HiSiaddi customer service if you need more comparison and analysis of brands and models.
The buyer is NaturaPrime, a premium nutrition brand headquartered in Munich, Germany. It specializes in pharmacy-exclusive premium enteric-coated capsules, liposomal oral liquids and high-end sleep-aid soft candies sold across over 2,300 chain pharmacies and organic supermarkets nationwide in Germany. Its products comply with five access standards: USP, EU EFSA, German LFGB, NON-GMO and cGMP. Previously, its 5-HTP was long sourced from high-purity raw materials of an original French manufacturer. To optimize supply chain costs and shorten lead times, the brand planned localized procurement in China and independently contacted four major domestic 5-HTP factories for inquiry and sample delivery. However, each factory only promoted its own products. While politely avoiding negative comments on competitors, they declined to objectively state peer brand strengths, process weaknesses and applicable scenarios. The client could not distinguish between extraction and biosynthetic production routes, physicochemical differences of various models and impurity control standards. Physicochemical indicators of 5 received samples varied drastically, failing to match its dual capsule & soft candy production lines. The client entrusted HiSiaddi to sort out domestic mainstream brands and models neutrally for targeted sourcing.
1. Two categories of raw materials required: ① Low-moisture-absorption granular 5-HTP for capsules (no punch sticking during filling, impurities ≤0.01%); ② Water-soluble modified powder for soft candies (105°C heat-resistant, fully soluble in cold water without precipitation).
2. CNAS & USP dual-method COA available for all batches; factories must hold EU export filing qualifications with stable annual supply capacity ≥1 ton.
1. Each brand only promotes self-owned products with one-sided information After contacting VDK, Zhejiang Medicine, Luwei Pharmaceutical and Guangji Pharmaceutical, sales representatives of each factory only introduced their own product strengths, production capacity and certifications. When asked about peer advantages, they uniformly replied "we do not comment on competitors and recommend priority purchase of our models", providing no objective horizontal parameter comparisons, leaving the client unable to distinguish essential gaps between extraction and biosynthetic raw materials.
2. Wide variance in measured indicators for products labeled with identical 99% purity Some extracted products labeled USP grade were detected with Peak X impurity peaks and excessive moisture absorption upon testing, while some biosynthetic variants carried premium pricing. The client could not identify corresponding advantages of price premiums or match differentiated raw materials for its capsule and soft candy production lines.
3. Complex uncategorized models with no clear distinction between standard & customized modified variants Each brand launches 3~4 segmented models with non-unified naming standards. Factories prioritize high-margin models without matching specifications to the client’s terminal dosage forms, resulting in sample waste.
Independent of supply cooperation interests, HiSiaddi objectively sorted out five top domestic brands: VDK Bio, Zhejiang Medicine, Shandong Luwei, Hubei Guangji Pharmaceutical and Jiangsu Tianrui Pharma, analyzing their production processes, core models, strengths, weaknesses and applicable terminal scenarios one by one, and delivered bilingual Chinese-English comparison data sheets to the client.
1. VDK Bio (VDK®, Biosynthetic Process)
1. Core Models: ① USP1 ultra-white sustained-release granular grade; ② USP2 water-soluble modified powder grade; ③ national standard extracted powder grade
2. Strengths: Full fermentation process free of plant exogenous impurities, pre-peak impurities ≤0.01%, no detectable Peak X impurities; customizable granules and water-soluble modified variants suitable for premium capsules and soft candies.
3. Weaknesses: Customized variants carry relatively high unit prices; sample trial lead time 3~5 days for small batches (<50kg).
2. Zhejiang Medicine (ZMC, Dual Extraction & Synthesis Lines)
1. Core Models: ① USP high-purity extracted powder; ② pharmaceutical-grade synthetic API; ③ food-grade standard extracted powder
2. Strengths: Established listed pharmaceutical enterprise with full FDA & EU GMP certifications, sufficient mass production reserves and strong price advantages for bulk orders; extracted raw materials feature natural origin attributes.
3. Weaknesses: No self-developed water-soluble modified specifications; granule production requires outsourced granulation with long customized modification lead times.
3. Shandong Luwei Pharmaceutical (LUWEI, Plant Extraction-Oriented)
1. Core Models: 98.5% national standard powder, 99% USP extracted powder (two basic models only)
2. Strengths: Major amino acid manufacturer with stable powder performance and ample stock; outstanding cost performance for standard powder.
3. Weaknesses: No sustained-release granular or water-soluble modified products in full product line; raw materials feature high moisture absorption, only suitable for ordinary tablets, incompatible with soft candies and automatic capsule filling.
4. Hubei Guangji Pharmaceutical (GJ, Enzymatic Catalysis Synthesis)
1. Core Models: Pharmaceutical-grade high-purity synthetic powder, dietary supplement-grade synthetic powder
2. Strengths: Green enzymatic process with stringent heavy metal control, compliant with European pharmaceutical raw material access requirements.
3. Weaknesses: No granular dosage forms; limited modified R&D production capacity unable to mass-produce customized water-soluble specifications.
5. Jiangsu Tianrui Pharma (TR, Mixed Fermentation & Extraction Process)
1. Core Models: Economy-grade 98% extracted powder, mid-tier 98.8% fermented powder
2. Strengths: Optimal cost, suitable for mass-market general dietary supplement bulk commodities.
3. Weaknesses: Impurity indicators only meet national standards, failing stringent limits of German TGA and USP, unsuitable for premium pharmacy product lines.
Considering the client’s dual capsule & soft candy production lines and German pharmacy high-end access requirements, Luwei and Tianrui were eliminated (lack of modified specifications or substandard indicators). Two mid-to-high-end brands and three segmented models were finalized:
1. VDK USP1 ultra-white sustained-release granules (for capsules): Low-moisture-absorption biosynthetic granules with qualified angle of repose and no machine sticking during filling, pre-peak impurities ≤0.01%, fully compatible with automatic capsule production lines.
2. VDK USP2 water-soluble modified powder (for soft candies): Encapsulation-modified heat-resistant variant with boiling loss <3.5% at 105°C, instant cold-water dissolution without precipitation, perfectly matching soft candy formulas.
3. Zhejiang Medicine USP high-purity extracted powder (backup inventory reserve): Natural Griffonia simplicifolia high-purity extracted powder for the client’s low-cost auxiliary tablet sub-line, with ample stock to balance overall procurement costs.
1. HiSiaddi coordinated free sample delivery from three parties. Full USP testing conducted at the client’s German laboratory confirmed VDK’s two modified raw materials passed TGA preliminary review, while Zhejiang Medicine’s extracted powder met standards for backup use.
2. The client finalized an annual framework order of 980kg: 450kg VDK granules + 330kg water-soluble powder + 200kg Zhejiang Medicine high-purity extracted powder, shipped via constant-temperature sea transport in 8 batches.
3. Post-production results: Smooth capsule filling without material blockage, fully transparent soft candies free of white precipitate spots. Finished products successfully launched across all German pharmacy channels. Compared with original French imported raw materials, comprehensive procurement costs decreased by 31%, and sea transport lead time was shortened from 52 days to 26 days.
1.
Extended Cooperation The following year, NaturaPrime fully entrusted HiSiaddi with domestic model selection and procurement for supporting raw materials including GABA and tryptophan. Supported by the endorsement of this premium German brand, VDK Bio and Zhejiang Medicine secured designated procurement orders from two additional European pharmacy brands in the Netherlands and Austria.
2.
3.
Summary of Industry Pain Points Sales teams of major domestic raw material manufacturers prioritize marketing self-owned products constrained by performance KPIs and will not actively introduce peer advantages objectively. Mid-to-high-end overseas brands lack familiarity with domestic production processes and brand segmentation, easily mismatching raw materials and triggering finished product scrapping during independent sourcing. Acting as a neutral third-party foreign trade service provider unbound by single factory interests, HiSiaddi leverages a full industrial chain database for horizontal comparison of brand parameters and accurately matches models to terminal dosage forms, resolving cross-border information gaps and supporting overseas high-end brands to smoothly implement localized procurement in China.
4.
Please contact HiSiaddi customer service if you need more comparison and analysis of brands and models.
+86-13120989737 
info@hisiaddi.com 
English
